Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 Mar;48(3):201–205. doi: 10.1136/ard.48.3.201

Anti-IgE autoantibodies in systemic sclerosis (scleroderma).

L D Kaufman 1, B L Gruber 1, M J Marchese 1, J R Seibold 1
PMCID: PMC1003721  PMID: 2930275

Abstract

An enzyme immunoassay was used to determine the prevalence of anti-IgE auto-antibodies in 66 patients with systemic sclerosis (scleroderma) stratified according to extent and duration of disease. Serum IgG anti-IgE antibodies were detected in 14 (21%) patients and IgM anti-IgE antibodies in nine (14%) patients. The overall prevalence of IgG or IgM isotypes was 21/66, (32%). Anti-IgE autoantibodies were not found in six patients with undifferentiated connective tissue disease or two patients with eosinophilic fasciitis. Attempts to demonstrate histamine release from basophils in vitro by using serum samples containing high titre anti-IgE antibody were unsuccessful. By multivariate analysis the presence of anti-IgE antibody was not associated with duration of systemic sclerosis; extent of scleroderma; specific visceral features, including heart, lung, renal, and gastrointestinal involvement; or mortality.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins F. M., Friedman M. M., Subba Rao P. V., Metcalfe D. D. Interactions between mast cells, fibroblasts and connective tissue components. Int Arch Allergy Appl Immunol. 1985;77(1-2):96–102. doi: 10.1159/000233760. [DOI] [PubMed] [Google Scholar]
  2. Beaven M. A., Jacobsen S., Horáková Z. Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine. Clin Chim Acta. 1972 Mar;37:91–103. doi: 10.1016/0009-8981(72)90419-6. [DOI] [PubMed] [Google Scholar]
  3. Carini C., Fratazzi C., Barbato M. IgG autoantibody to IgE in atopic patients. Ann Allergy. 1988 Jan;60(1):48–52. [PubMed] [Google Scholar]
  4. Claman H. N. Mast cell depletion in murine chronic graft-versus-host disease. J Invest Dermatol. 1985 Apr;84(4):246–248. doi: 10.1111/1523-1747.ep12265302. [DOI] [PubMed] [Google Scholar]
  5. Dabrowski R., Szczepanowska A. Alterations in histamine and collagen induced in chick embryos by aminoguanidine and 48/80. Agents Actions. 1984 Apr;14(3-4):458–460. doi: 10.1007/BF01973849. [DOI] [PubMed] [Google Scholar]
  6. Fleischmajer R., Perlish J. S., Reeves J. R. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 1977 May;20(4):975–984. doi: 10.1002/art.1780200410. [DOI] [PubMed] [Google Scholar]
  7. Fonseca E., Solís J. Mast cells in the skin: progressive systemic sclerosis and the toxic oil syndrome. Ann Intern Med. 1985 Jun;102(6):864–865. doi: 10.7326/0003-4819-102-6-864_2. [DOI] [PubMed] [Google Scholar]
  8. Franzén L. Further studies on the relationship between drug-induced mast-cell secretion and local cell proliferation. Acta Pathol Microbiol Scand A. 1981 Jan;89(1):57–62. doi: 10.1111/j.1699-0463.1981.tb00187.x. [DOI] [PubMed] [Google Scholar]
  9. Gruber B. L., Kaufman L. D., Marchese M. J., Roth W., Kaplan A. P. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug;31(8):1000–1006. doi: 10.1002/art.1780310810. [DOI] [PubMed] [Google Scholar]
  10. Hawkins R. A., Claman H. N., Clark R. A., Steigerwald J. C. Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann Intern Med. 1985 Feb;102(2):182–186. doi: 10.7326/0003-4819-102-2-182. [DOI] [PubMed] [Google Scholar]
  11. Inganäs M., Johansson S. G., Bennich H. Anti-IgE antibodies in human serum: occurrence and specificity. Int Arch Allergy Appl Immunol. 1981;65(1):51–61. doi: 10.1159/000232737. [DOI] [PubMed] [Google Scholar]
  12. Johansson S. G. Anti-IgE antibodies in human serum. J Allergy Clin Immunol. 1986 Apr;77(4):555–557. doi: 10.1016/0091-6749(86)90344-1. [DOI] [PubMed] [Google Scholar]
  13. Kaplan A. P., Haak-Frendscho M., Fauci A., Dinarello C., Halbert E. A histamine-releasing factor from activated human mononuclear cells. J Immunol. 1985 Sep;135(3):2027–2032. [PubMed] [Google Scholar]
  14. LICHTENSTEIN L. M., OSLER A. G. STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN. J Exp Med. 1964 Oct 1;120:507–530. doi: 10.1084/jem.120.4.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A., Jr, Rowell N., Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988 Feb;15(2):202–205. [PubMed] [Google Scholar]
  16. Menton D. N., Hess R. A., Lichtenstein J. R., Eisen A. The structure and tensile properties of the skin of tight-skin (Tsk) mutant mice. J Invest Dermatol. 1978 Jan;70(1):4–10. doi: 10.1111/1523-1747.ep12543353. [DOI] [PubMed] [Google Scholar]
  17. Metcalfe D. D., Kaliner M., Donlon M. A. The mast cell. Crit Rev Immunol. 1981 Sep;3(1):23–74. [PubMed] [Google Scholar]
  18. Nawata Y., Koike T., Hosokawa H., Tomioka H., Yoshida S. Anti-IgE autoantibody in patients with atopic dermatitis. J Immunol. 1985 Jul;135(1):478–482. [PubMed] [Google Scholar]
  19. Nawata Y., Koike T., Yanagisawa T., Iwamoto I., Itaya T., Yoshida S., Tomioka H. Anti-IgE autoantibody in patients with bronchial asthma. Clin Exp Immunol. 1984 Nov;58(2):348–356. [PMC free article] [PubMed] [Google Scholar]
  20. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980 May;23(5):581–590. doi: 10.1002/art.1780230510. [DOI] [PubMed] [Google Scholar]
  21. Seibold J. R., Harris J. N. Plasma beta-thromboglobulin in the differential diagnosis of Raynaud's phenomenon. J Rheumatol. 1985 Feb;12(1):99–103. [PubMed] [Google Scholar]
  22. Walker M. A., Harley R. A., LeRoy E. C. Inhibition of fibrosis in TSK mice by blocking mast cell degranulation. J Rheumatol. 1987 Apr;14(2):299–301. [PubMed] [Google Scholar]
  23. Walker M., Harley R., Maize J., DeLustro F., LeRoy E. C. Mast cells and their degranulation in the Tsk mouse model of scleroderma. Proc Soc Exp Biol Med. 1985 Nov;180(2):323–328. doi: 10.3181/00379727-180-42183. [DOI] [PubMed] [Google Scholar]
  24. Williams R. C., Jr, Griffiths R. W., Emmons J. D., Field R. C. Naturally occurring human antiglobulins with specificity for E. J Clin Invest. 1972 Apr;51(4):955–963. doi: 10.1172/JCI106890. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES